Effect of selenium on thyroid hormone metabolism in filial cerebrum of mice with excessive iodine exposure

Biological Trace Element Research

Volumn 113, Issue 3, 2006, Pages 281-295

  Guo, Huailan ^a,b   Yang, Xuefeng ^a   Xu, Jian ^a   Hou, Xiaohui ^a   Sun, Xiufa ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Cerebrum; Deiodinase; Excessive iodine; Filial; Selenium; Thyroid hormone

Indexed keywords

IODINE; LIOTHYRONINE; POTASSIUM IODATE; SELENIUM; SODIUM SELENITE; THYROID HORMONE; THYROXINE; THYROXINE DEIODINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; EXPOSURE; FEMALE; INTOXICATION; IODINE OVERLOAD; LIOTHYRONINE BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PERINATAL PERIOD; PROGENY; THYROID HORMONE METABOLISM; THYROXINE BLOOD LEVEL;

ANIMALS; ANIMALS, NEWBORN; FEMALE; IODINE; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED BALB C; SELENIUM; TELENCEPHALON; THYROID HORMONES; THYROXINE; TIME FACTORS; TRIIODOTHYRONINE;

EID: 33845956179     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:113:3:281     Document Type: Article

References (47)

1. S. P. Porterfield and C. E. Hendrich, The role of thyroid hormones in prenatal and neonatal neurological development: current perspectives, Endocr. Rev. 14, 94-106 (1993).
2. D. A. Fisher and A. H. Klein, Thyroid development and disorders of thyroid function in the newborn, N. Engl. J. Med. 304, 702-712 (1981).
3. A. Costa, R. Arisio, C. Benedetto, et al., Thyroid hormones in tissues from human embryos and fetuses, J. Endocrinol. Invest. 14, 559-568 (1991).
4. A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases, Endocr. Rev. 23, 38-89 (2002).
5. R. T. Zoeller, Transplacental thyroxine and fetal brain development, J. Clin. Invest. 111, 954-957 (2003).
6. J. Bernal, Action of thyroid hormone in brain, J. Endocrinol. Invest. 25, 268-288 (2002).
7. F. R. Crantz, J. E. Silva, and P. R. Larsen, An analysis of the sources and quantity of 3,5,3′-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum, Endocrinology 110, 367-375 (1982).
8. M. J. Berry, L. Banu, and P. R. Larsen, Type I iodothyronine deiodinase is a selenocysteine-containing enzyme, Nature 349, 438-440 (1991).
9. W. Croteau, S. L. Whittemore, M. J. Schneider, and D. L. St. Germain, Cloning and expression of a cDNA for a mammalian type III iodothyronine deiodinase, J. Biol. Chem. 270, 16,569-16,575 (1995).
10. C. Buettner, J. W. Harney, and P. R. Larsen, The 3'-untranslated region of the human type 2 iodothyronine deiodinase mRNA contains a functional selenocysteine insertion sequence, J. Biol. Chem. 273, 33,374-33,378 (1998).
11. J. M. Bates, V. L. Spate, and J. S. Morris, Effects of selenium deficiency on tissue selenium content, deiodinase activity, and thyroid hormone economy in the rat during development, Endocrinology 141, 2490-2500 (2000).
12. Z. Chen, D. Liu, and Y. Yang, High iodine region and endemic iodine-induced goiter, Chinese, J. Endemiol. 17, 385-386 (1998).
13. E. N. Pearce, A. R. Gerber, D. B. Gootnick, et al., Effects of chronic iodine excessive in a cohort of long-term American workers in west Africa, J. Clin. Endocrinol. Metab. 87, 5499-5502 (2002).
14. K. Norimichi, M. Horini, Y. Kenji, I. Norio, and K. Kimio, Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan, J. Clin. Endocrinol. Metab. 78, 393-397 (1994).
15. J. Zhao, Z. Chen, and G. F. Maberly, Iodine-rich drinking water of natural origin in China, Lancet 352, 2024 (1998).
16. E. Martino, L. Bartalena, F. Bogazzi, and L. E. Braverman, The effects of amiodarone on the thyroid, Endocr. Rev. 22, 240-254 (2001).
17. F. Delange, B. de Benoist, and D. Alnwick, Risks of iodine-induced hyperthyroidism after correction of iodine deficiency by iodized salt, Thyroid 9, 545-556 (1999).
18. J. Zhao, P. Wang, L. Shang, K. M. Sullivan, F. van der Haar, and G. Maberly, Endemic goiter associated with high iodine intake, Am. J. Public Health 90, 1633-1635 (2000).
19. N. Georgopoulos, V. Kyriazopoulou, and A. G. Vagenakis, Iodine-induced hypothyroidism, Thyroid 11, 501-510 (2001).
20. E. Roti and E. D. Uberti, Iodine excessive and hyperthyroidism, Thyroid 11, 493-500 (2001).
21. M. J. Obregon, F. E. Del Rey, and G. M. de Escobar, The effects of iodine deficiency on thyroid hormone deiodination, Thyroid 15, 917-929 (2005).
22. P. Cinaz, D. S. Karakasu, M. O. Camurdan, A. Bideci, E. D. Ayvali, and C. Yucel, Goiter prevalence, serum selenium, and urine iodine status in a previously iodine-deficient area in Turkey, Biol. Trace Element Res. 100, 185-193 (2004).
23. T. Wu, J. Wang, and G. Liu, A new hypothesis about iodine-induced goiter and hyperthyroidism: deiodinase activity decrease theory, W. China Med. J. 115, 405-408 (2000).
24. H. Xiaohui, Y. Xuefeng, P. Hong, et al., Effect of selenium on liver type I deiodinase iniodine excess mice, Wei Sheng Yan Jiu 33(6), 678-680 (2004).
25. 4+, Anal. Chem. 69, 687-689 (1986).
26. I. H. Watkinson, Fluorometric determination of selenium in biological material with 2,3-diaminonaphthalene, Anal. Chem. 38, 92-97 (1966).
27. J. G. Cook, Factors influencing the assay of creatinine, Ann. Clin. Biochem. 12, 219-232 (1975).
28. C. A. Furnee, F. van der Haar, C. E. West, and J. G. A. J. Hautvast, Acritical appraisal of goiter assessment and the ratio of urinary iodine to creatinine for evaluating iodine status, Am. J. Clin. Nutr. 59, 1415-1447 (1994).
29. A. M. Koopdonk-kool, Joland, J. M. Jan, D. E. Vijlder, et al., Type II and type III deiodinase activity in human placenta as a function of gestational age, J. Clin. Endocrinol. Metab. 6, 2154-2158 (1996).
30. O. H. Lowry, N. J. Rosebrough, A. L. Farr, et al., Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265-269 (1951).
31. G. J. Beckett, Russella, Nicolf, et al., Effect of selenium deficiency on hepatic type I 5′-iodothyronine deiodinase activity and hepatic thyroid hormone levels in the rat, Biochem. J. 282(Pt. 2), 483-486 (1992).
32. C. Zupei and S. Yanqing, Iodine-induced hyperthyroidism, Chin. J. Endemiol. 19, 73-75 (2000).
33. S. Nishiyama, T. Mikeda, T. Okada, K. Nakamura, T. Kotani, and A. Hishinuma, Transient hypothyroidism or persistent hyperthyrotropinemia in neonates born to mothers with excessive iodine intake, Thyroid 14(12), 1077-1083 (2004).
34. National Research Council, Mineral Tolerance of Domestic Animals, National Academy Press, Washington, DC, p. 227 (1980).
35. L. Bartalena, F. Bogazzi, L. E. Braverman, and E. Martino, Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment, J. Endocrinol. Invest. 24, 116-130 (2001).
36. J. P. Chanoine, M. Safran, A. P. Farwell, et al., Selenium deficiency and type II 5′-deiodinase regulation in the euthyroid and hypothyroid rat: evidence of a direct effect of thyroxine, Endocrinology 130, 479-484 (1992).
37. M. M. Kaplan, U. D. McCann, K. A. Yaskoski, P. R. Larsen, and J. L. Leonard, Anatomical distribution of phenolic and tyrosyl ring iodothyronine deiodinases in the nervous system of normal and hypothyroid rats, Endocrinology 109, 397-402 (1981).
38. J. Köhrle, Selenium and the control of thyroid hormone metabolism, Thyroid 15, 841-853 (2005).
39. O. Broedel, M. Eravci, S. Fuxius, et al., Effects of hyper- and hypothyroidism on thyroid hormone concentrations in regions of the rat brain, Am. J. Physiol. Endocrinol. Metab. 285, E470-E480 (2003).
40. R. T. Zoeller and J. Rovet, Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings, J. Neuroendocrinol. 16, 809-818 (2004).
41. M. Qian, Y. Yan, Z. Chen, and D. Wang, Meta-analysis on the relationship between children's intelligence and factors as iodine deficiency, supplement iodine and excessive iodine, Zhonghua Liu Xing Bing Xue Za Zhi 23, 246-249 (2002).
42. P. Goyens, J. Golstein, B. Nsombola, H. Vis, and J. E. Dumont, Selenium deficiency as a possible factor in the pathogenesis of myxoedematous endemic cretinism, Acta. Endocrinol. 114, 497-502 (1987).
43. 2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid, Endocrinology 128, 779-785 (1991).
44. U. Björkman and R. Ekholm, Hydrogen peroxide degradation and glutathione peroxidase activity in cultures of thyroid cells, Mol. Cell Endocrinol. 111, 99-107 (1995).
45. J. H. Mitchell, F. Nicol, G. J. Beckett, and J. R. Arthur, Selenoenzyme expression in thyroid and liver of second generation selenium- and iodine-deficient rats, J. Mol. Endocrinol. 16, 259-267 (1996).
46. M. B. Zimmermann and J. Kohrle, The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health, Thyroid 12, 867-878 (2002).
47. X. F. Yang, H. Xiao-Hui, H. Pang, et al., Influence of high iodine intake on anti-oxidation ability in mice and intervention of selenium, Chinese Journal of Public Health, 20, 1081-1082 (2004).